NO163693C - Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.

Info

Publication number
NO163693C
NO163693C NO834089A NO834089A NO163693C NO 163693 C NO163693 C NO 163693C NO 834089 A NO834089 A NO 834089A NO 834089 A NO834089 A NO 834089A NO 163693 C NO163693 C NO 163693C
Authority
NO
Norway
Prior art keywords
platina
procedure
preparation
active compounds
therapeutic active
Prior art date
Application number
NO834089A
Other languages
English (en)
Norwegian (no)
Other versions
NO834089L (no
NO163693B (no
Inventor
Gaylord Darrell Smith
Douglas Scott Brown
Philip Bernstein
John Edward Weller
Original Assignee
Inco Res & Dev Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inco Res & Dev Center Inc filed Critical Inco Res & Dev Center Inc
Publication of NO834089L publication Critical patent/NO834089L/no
Publication of NO163693B publication Critical patent/NO163693B/no
Publication of NO163693C publication Critical patent/NO163693C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0013Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO834089A 1982-11-10 1983-11-09 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina. NO163693C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44044982A 1982-11-10 1982-11-10
US06/540,871 US4584392A (en) 1982-11-10 1983-10-14 Platinum and palladium complexes

Publications (3)

Publication Number Publication Date
NO834089L NO834089L (no) 1984-05-11
NO163693B NO163693B (no) 1990-03-26
NO163693C true NO163693C (no) 1990-07-04

Family

ID=27032420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834089A NO163693C (no) 1982-11-10 1983-11-09 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.

Country Status (11)

Country Link
US (1) US4584392A (fr)
EP (1) EP0111388B1 (fr)
AU (1) AU566785B2 (fr)
CA (1) CA1227133A (fr)
DE (1) DE3370485D1 (fr)
ES (1) ES527111A0 (fr)
FI (1) FI81006C (fr)
GR (1) GR79429B (fr)
IE (1) IE56211B1 (fr)
NO (1) NO163693C (fr)
PT (1) PT77635B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673754A (en) * 1983-10-14 1987-06-16 Inco Alloys International, Inc. Platinum and palladium complexes
GB8328218D0 (en) * 1983-10-21 1983-11-23 Johnson Matthey Plc Oral compositions
ES8801168A1 (es) * 1984-11-02 1987-02-16 Johnson Matthey Plc Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer.
CS253069B1 (en) * 1984-11-09 1987-10-15 Jaroslav Drobnik Macromolecular anticarcinogenetic remedy containing platinum and method of its production
IL73972A0 (en) * 1984-12-31 1985-03-31 Yeda Res & Dev Agents based on platinum compounds
WO1987007142A1 (fr) * 1986-05-21 1987-12-03 Kuraray Co., Ltd. Nouveaux complexes, procede pour leur preparation, et leur emploi medicinal
US5011959A (en) * 1986-11-17 1991-04-30 The Board Of Regents, The University Of Texas System 1,2-diaminocyclohexane-platinum complexes with antitumor activity
EP0284197A1 (fr) * 1987-02-20 1988-09-28 Tanabe Seiyaku Co., Ltd. Complexes organiques de platine et leur procédé de préparation
US4793986A (en) * 1987-02-25 1988-12-27 Johnson Matthey, Inc. Macromolecular platinum antitumor compounds
IL85595A0 (en) * 1987-03-06 1988-08-31 Tanabe Seiyaku Co Organic platinum complex and its preparation
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes
EP0307827A3 (fr) * 1987-09-15 1989-12-27 Kuraray Co., Ltd. Complexes moléculaires, procédé de préparation et utilisation en médecine
US4931553A (en) * 1988-05-11 1990-06-05 Gill Devinder S Platinum-polymer complexes and their use as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5352771A (en) * 1992-08-31 1994-10-04 Iowa State University Research Foundation Inc. Hydrolysis of peptide bonds using Pt (II) and Pd (II) complexes
US20070148721A1 (en) * 2005-12-28 2007-06-28 Agilent Technologies, Inc. Compositions, methods, systems, and kits for affinity purification
EP3577123B1 (fr) * 2018-02-06 2020-04-15 Wacker Chemie AG Procédé pour la préparation d'aminopropylalcoxysilanes
CN113995714B (zh) * 2021-10-28 2023-04-28 杭州师范大学 一种顺铂交联的蛋白水凝胶及制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH605550A5 (fr) * 1972-06-08 1978-09-29 Research Corp
GB1531211A (en) * 1975-10-27 1978-11-08 Rustenburg Platinum Mines Ltd Compounds and compositions containing platinum
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4356166A (en) * 1978-12-08 1982-10-26 University Of Utah Time-release chemical delivery system
US4376782A (en) * 1980-05-21 1983-03-15 Research Corporation Complexes of square planar platinum II compounds and N-methyl glucamine
JPS5851959B2 (ja) * 1980-06-11 1983-11-19 呉羽化学工業株式会社 プラチナ化合物とその医薬組成物

Also Published As

Publication number Publication date
NO834089L (no) 1984-05-11
ES8504631A1 (es) 1985-05-01
FI81006C (fi) 1990-09-10
EP0111388A3 (en) 1984-09-05
AU2110983A (en) 1984-05-17
NO163693B (no) 1990-03-26
CA1227133A (fr) 1987-09-22
IE832614L (en) 1984-05-10
EP0111388A2 (fr) 1984-06-20
IE56211B1 (en) 1991-05-22
ES527111A0 (es) 1985-05-01
DE3370485D1 (en) 1987-04-30
FI834129A0 (fi) 1983-11-10
FI81006B (fi) 1990-05-31
US4584392A (en) 1986-04-22
GR79429B (fr) 1984-10-22
EP0111388B1 (fr) 1987-03-25
PT77635A (en) 1983-12-01
AU566785B2 (en) 1987-10-29
PT77635B (en) 1986-03-19
FI834129A (fi) 1984-05-11

Similar Documents

Publication Publication Date Title
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO844853L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte trans-1,2-diaminocyklohexyk-amid-forbindelser
NO832431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO161002C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive polypeptider.
NO831610L (no) Fremgangsmaate for fremstilling av terapeutisk aktive oxicamderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO834729L (no) Fremgangsmaate for fremstilling av farmakologisk aktive tio-cefalosporiner
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO830900L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO163529C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte azabicykloalkaner.
NO160001C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.
NO158579C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt n-(2-metoksyetyl)-noroksymorfon.
NO155842C (no) Analogifremgangsmaate ved fremstilling av terapeutiske aktive 2-beta-d-ribofuranosylselenazol-4-carboxamider.